Prosecution Insights
Last updated: April 19, 2026

Clark+Elbing LLP - Moderna

8 pending office actions • 3 clients

Portfolio Summary

8
Total Pending OAs
1
Final Rejections
7
Non-Final OAs

Client Portfolio (3 clients)

Client (Assignee)Pending OAs
Modernatx, Inc. 6
Modernatx, Inc. 1
Modema Tx, Inc. 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18682685 LIPID NANOPARTICLE FORMULATIONS AND METHODS OF SYNTHESIS THEREOF Modernatx, Inc. TRUONG, QUANGLONG N 1615 Non-Final OA Feb 09, 2024
18284395 SYNTHESIS OF TRINUCLEOTIDE AND TETRANUCLEOTIDE CAPS FOR MRNA PRODUCTION Modernatx, Inc. LEWIS, PATRICK T 1691 Non-Final OA Sep 27, 2023
18036992 RIBONUCLEIC ACID PURIFICATION Modernatx, Inc. ZARA, JANE J 1637 Non-Final OA May 15, 2023
18177455 MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS Modernatx, Inc. LEONARD, ARTHUR S 1631 Non-Final OA Mar 02, 2023
18161857 METHODS FOR PREPARING PARTICLES AND RELATED COMPOSITIONS Modernatx, Inc. GREENE, IVAN A 1619 Final Rejection Jan 30, 2023
18161598 MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS Modema Tx, Inc. VANHORN, ABIGAIL LOUISE 1636 Non-Final OA Jan 30, 2023
18058656 MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF Modernatx, Inc. SINGH, ANOOP KUMAR 1632 Non-Final OA Nov 23, 2022
17276983 COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS Modernatx, Inc. JOHNSON, ALLISON MARIE 1638 Non-Final OA Mar 17, 2021

Managing Clark+Elbing LLP - Moderna's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month